Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Timmerman

Bioanalysis

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Bioanalysis|August 6, 2021
A brave new world?Philip Timmerman
Bioanalysis|March 14, 2014
Tiered approach revisited: introducing stage-appropriate or assay-appropriate scientific validationPhilip Timmerman
Bioanalysis|April 5, 2019
A note from the European Bioanalysis Forum (EBF)Philip Timmerman
Bioanalysis|November 14, 2018
Incurred sample reproducibility: what have we learned and how can we build on our learnings?Philip Timmerman
Bioanalysis|March 14, 2014
Tiered approach: from plan into practicePhilip Timmerman
Bioanalysis|July 16, 2016
Biomarker assay validation: are we having the right discussions?Philip Timmerman
Bioanalysis|February 28, 2019
Incurred sample reproducibilityFaye Vazvaei, Philip Timmerman
Bioanalysis|September 24, 2013
LC-MS/MS of large molecules in a regulated bioanalytical environment - which acceptance criteria to apply?Magnus Knutsson, Ronald Schmidt, Philip Timmerman
Bioanalysis|April 26, 2016
Microscale bioanalysisMagnus Knutsson, Philip Timmerman, Frank A Gomez
Bioanalysis|December 24, 2010
A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical speciesLieve Dillen, Willy Cools, Liesbeth Vereyken, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Bioanalysis|August 6, 2021
A brave new world?Philip Timmerman
Bioanalysis|March 14, 2014
Tiered approach revisited: introducing stage-appropriate or assay-appropriate scientific validationPhilip Timmerman
Bioanalysis|April 5, 2019
A note from the European Bioanalysis Forum (EBF)Philip Timmerman
Bioanalysis|November 14, 2018
Incurred sample reproducibility: what have we learned and how can we build on our learnings?Philip Timmerman
Bioanalysis|March 14, 2014
Tiered approach: from plan into practicePhilip Timmerman
Bioanalysis|July 16, 2016
Biomarker assay validation: are we having the right discussions?Philip Timmerman
Bioanalysis|February 28, 2019
Incurred sample reproducibilityFaye Vazvaei, Philip Timmerman
Bioanalysis|September 24, 2013
LC-MS/MS of large molecules in a regulated bioanalytical environment - which acceptance criteria to apply?Magnus Knutsson, Ronald Schmidt, Philip Timmerman
Bioanalysis|April 26, 2016
Microscale bioanalysisMagnus Knutsson, Philip Timmerman, Frank A Gomez
Bioanalysis|December 24, 2010
A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical speciesLieve Dillen, Willy Cools, Liesbeth Vereyken, et al.
Pageof 11